Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study
Purpose: To study post-interventional findings in patients with dysthyroid optic neuropathy (DON) treated with teprotumumab. Observations: In this multicenter observational Case series, patients with DON were treated with teprotumumab, an insulin-like growth factor I receptor inhibitor (10 mg/kg for...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-09-01
|
| Series: | American Journal of Ophthalmology Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993621001201 |